Wednesday, November 18, 2026 | 12:35 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India's lower health spending burden still masks gaps in public care

Pharmaceuticals accounted for 30.2 per cent of current health expenditure, while outpatient curative care accounted for 19.3 per cent

healthcare, doctor
premium

Private hospitals accounted for around 31.9 per cent of current health expenditure, almost twice the 15.9 per cent spent through government hospitals (Photo: AdobeStock)

Business Standard Editorial Comment

Listen to This Article

The latest estimates of the National Health Accounts (NHA) show India’s financing for health care has become less dependent on households, but this should not be mistaken for adequate public investment or universal financial protection. The share of out-of-pocket expenditure (OOPE) in total health spending indeed declined from 64.2 per cent in 2013-14 to 42.7 per cent in 2023-24. Over the same period, the government’s share rose from 28.6 per cent to 43.5 per cent. Government health expenditure increased to ₹4.14 trillion, nearly three times its level a decade earlier. These are significant shifts. But the increase is in nominal terms; more importantly, government health expenditure was only 1.43 per cent of gross domestic product in 2023-24, as against the National Health Policy 2017 target of 2.5 per cent by 2025. The target remains unmet. 
At the same time, a lower OOPE share does not mean that households are no longer bearing a burden. Per capita OOPE rose from ₹2,767 in 2022-23 to ₹2,901 in 2023-24. The decline in the share must, therefore, be read alongside the absolute amount and the continuing risk of households incurring high costs when they need treatment. Insurance coverage also deserves attention in this context. The latest National Family Health Survey-6 (NFHS-6) fact sheet reports that 60.2 per cent of households had at least one usual member covered by a health-insurance or financing scheme in 2023-24, up from 41 per cent in NFHS-5. This is encouraging, but the indicator is household-based: It does not mean that 60.2 per cent of individuals have comprehensive insurance. The NHA estimates record ₹97,167 crore in private health-insurance expenditure and ₹33,385 crore under government-financed insurance schemes in 2023-24. The Pradhan Mantri Jan Arogya Yojana (PM-JAY) provides up to ₹5 lakh per family for secondary and tertiary hospitalisation, but insurance-led protection does not automatically cover the costs of outpatient consultations, medicines and diagnostics. 
The composition of health care spending points to why public provision remains central. Pharmaceuticals accounted for 30.2 per cent of current health expenditure, while outpatient curative care accounted for 19.3 per cent. These are expenses that can recur and weigh heavily on households. Private hospitals accounted for around 31.9 per cent of current health expenditure, almost twice the 15.9 per cent spent through government hospitals. Expanding insurance without adequate public facilities risks financing treatment in a system where private providers remain a bigger part of delivery. The Centre cannot meet this challenge alone and states accounted for about 68 per cent of government health expenditure in 2023-24. However, their fiscal capacity and health infrastructure vary considerably. Government spending is directed substantially towards primary care, which accounts for around 51 per cent of its current health expenditure, as it should. However, this must translate into functioning facilities, adequately staffed centres, reliable supplies of medicines, diagnostic services, and accessible outpatient care. The NHA numbers mark genuine progress in the way health care is financed. But a falling OOPE share needs to be seen in the overall context. The priority must be to raise public-health spending towards the stated target while strengthening primary care and public hospitals.